Dravet syndrome: A genetic epileptic disorder

Acta Medica Okayama

Volumn 66, Issue 5, 2012, Pages 369-376

  Akiyama, Mari ^a   Kobayashi, Katsuhiro ^a   Ohtsuka, Yoko ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Dravet syndrome; Long term outcome; PCDH19; SCN1A

Indexed keywords

CADHERIN; PCDH19 PROTEIN, HUMAN; SCN1A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.1;

ELECTROENCEPHALOGRAPHY; GENETICS; GENOTYPE; HUMAN; MUTATION; MYOCLONUS EPILEPSY; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW;

CADHERINS; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; GENOTYPE; HUMANS; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; PHENOTYPE;

EID: 84873732250     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Dravet C: Les epilepsies graves de I'enfant. Vie Med (1978) 8 543-548.
2. Dravet C, Bureau M, Oguni H, Fukuyama Y and Cokar 0: Severe myoclonic epilepsy in infancy (Dravet syndrome); in Epileptic syn-dromes in infancy, childhood and adolescence, Roger J, Bureau M Dravet C, Genton P, Tassinari CA, and Wolf P eds, 4th Ed, John Libbey Eurotext, Paris (2005) pp89-113
3. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW: Moshe SL, Nordli D, Plouin P and Scheffer IE: Revised terminol-ogy and concepts for organization of seizures and epilepsies report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia (2010) 51: 676-685.
4. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C and De Jonghe P: De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet (2001) 68: 1327-1332.
5. Dravet C and Guerrini R: Clinical and EEG Description; in Dravet Syndrome, John Libbey Eurotext, Paris (2011) pp9-36.
6. Oguni H, Hayashi K, AwayaY, Fukuyama Y and Osawa M: Severe myoclonic epilepsy in infants - a review based on the Tokyo Women's medical university series of 84 cases. Brain Dev (2001) 23: 736-748.
7. Akiyama M, Kobayashi K, Yoshinaga H and Ohtsuka Y: A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia (2010)51: 1043-1052.
8. Ogino T. Ohtsuka Y, Amano R, Yamatogi Y and Ohtahara S: An investigation on the borderland of severe myoclonic epilepsy in infancy. Jpn J Psychiatry Neural (1988) 42: 554-555.
9. Hattori J, Ouchida M, Ono J, Miyake S, Maniwa S, Mimaki N Ohtsuka Y and Ohmori I: A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia (2008) 49 626-633.
10. Fujiwara T, Sugawara T, Mazaki-Miyazaki E, Takahashi Y. Fukushima K, Watanabe M, Hara K, Morikawa T, Yagi K. Yamakawa K and Inoue Y: Mutations of sodium channel alpha subunit type 1 [SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain (2003) 126 (Pt3) 531-546.
11. Ohmori I, Ohtsuka Y, Ouchida M, Ogino T, Maniwa S, Shimizu K and Oka E: Is phenotype difference in severe myoclonic epilepsy in infancy related to SCN1A mutations? Brain Dev (2003) 25: 488-493.
12. Oguni H, Hayashi K, Osawa M, AwayaY, Fukuyama Y, Fukuma G Hirose S, Mitsudome A and Kanako S: Severe myoclonic epilepsy in infancy: clinical analysis and relation to SCN1A mutations in a Japanese cohort; in Advances in neurology, vol 95, Myoclonic Epilepsies, Delgado-Escueta V, Guerrini R, Medina MT, Genton P. Bureau M, and Dravet C eds, Lippincott Williams & Wilkins Philadelphia (2005) pp103-117.
13. Bureau M and Dalla Bernardia B: Electroencephalographic char-acteristics of Dravet Syndrome. Epilepsia (2011) 52 (Suppl. 2) 13-23.
14. Morimoto T, Hayakawa T, Sugie H, Awaya Y and Fukuyama Y: Epileptic seizures precipitated by constant light, movement in daily life, and hot water immersion. Epilepsia (1985) 26: 237-242
15. Ragona F, Brazzo D, De Giorgi I, Morbi M, Freri E, Teutonica F Gennaro E, Zara F, Binelli S, Veggiotti P and Granata T: Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian Patients. Brain Dev (2010) 32: 71-77.
16. Ohki T, Watanabe K, Negoro K, Aso K, Haga Y, Kasai K, Kito M and Maeda N: Severe myoclonic epilepsy in infancy: evolution of seizures. Seizure (1997) 6: 219-224.
17. Jansen FE, Sadleir LG, Harkin LA, Vadlamudi L, McMahon JM Mulley JC, Scheffer IE and Berkovic SF: Severe myoclonic epi-lepsy of infancy (Dravet syndrome): Recognition and diagnosis in adults. Neurology (2006) 67: 2224-2226.
18. Dravet C, Daquin G and Battaglia D: Severe myoclonic epilepsy of infancy (Dravet syndrome); in Long-term evolution of epileptic encephalopathies, Nikanorova M, Genton P, and Sabers A eds, John Libbey Eurotext, Paris (2009) pp29-38.
19. Genton P, Velizarova R and Dravet C: Dravet syndrome: The long-term outcome. Epilepsia (2011) 52 (S2): 44-49.
20. Ohtsuka Y, Maniwa S, Ogino T, Yamatogi Y and Ohtahara S: Severe myoclonic epilepsy in infancy: a long-term follow-up study. Jpn J Psychiatry Neural (1991) 45: 416-418.
21. Kobayashi K, Ohmori I, Ouchida M and Ohtsuka Y: Dravet syn-drome with an exceptionally good seizure outcome in two adoles-cents. Epileptic Disord (2011) 13: 340-344
22. Rossi PG, Santucci M, Gobbi G, Parmeggiani A, Pini A and Ambrosetto G: Long-term follow-up of severe myoclonic epilepsy in infancy; in Modern perspectives of child neurology, Fukuyama Y. Kamoshita S, Ohtsuka C, and Suzuki Y eds, Asahi Daily News, Tokyo (1991) pp205-213.
23. Mulley JC, Nelson P, Guerrero S, Dibbens L, Lona X, McMahon JM, Harkin L, Schouten J, Yu S, Berkovic SF and Scheffer IE: A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology (2006) 67: 1094-1095.
24. Marini C, Mei D, Temudo T, Ferrari AR, Buti D, Dravet C, Dias Al, Moreira A, Calado E, Seri S, Neville B, Narbona J, Reid E. Michelucci R, Sicca F, Cross HJ and Guerrini R: Idiopathic epi-lepsies with seizures precipitated by fever and SCN1A abnormali-ties. Epilepsia (2007) 48: 1678-1685.
25. Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I Bouteiller D, CarpentierW, Keren B, Abert B, GautierA, Baulac S Arzimanoglou A, Cazeneuve C, Nabbout R and LeGuern E Spectrum of SCN1A gene mutations associated with Dravet syndrome: Analysis of 333 patients. J Med Genet (2009) 46: 183-191.
26. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G An-Gourfinkel I, Brice A, LeGuern E, Moulard B, Chaigne D Buresi C and Malafosse A: Mutations of SCN1A, encoding a neu-ronal sodium channel, in two families with GEFS+2. Nat Genet (2000) 24: 343-345.
27. Scheffer IE, Zhang YH, Jansen FE and Dibbens L: Dravet syn-drome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev (2009) 31: 394-400.
28. Singh R, Andermann E, Whitehouse WP, Harvey AS, Keene DL Seni MH, Crossland KM, Andermann F, Berkovic SF and Scheffer IE: Severe myoclonic epilepsy of infancy: extended spectrum of GEFS + ? Epilepsia (2001) 42: 837-844.
29. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F Burton KA, Spain WJ, McKnight GS, Scheuer T and Catteral WA: Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci (2006)9: 1142-1149.
30. Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I Takeuchi T, Itohara S, Yanagawa Y, Obata K, Furuichi T. Hensch TK and Yamakawa K: Na(v)1.1 localizes to axons of par-valbumin-positive inhibitory interneurons: a circuit basis for epilep-tic seizures in mice carrying an Scnla gene mutation. J Neurosci (2007) 27: 5903-5914.
31. Dravet C and Guerrini R: The genetics of Dravet syndrome; in Dravet Syndrome, John Libbey Eurotext, Paris (2011) pp51-59.
32. Suls A, Claeys KG, Goossens D, Harding B, Van Luijk R Scheers S, Deprez L, Audenaert D, Van Dyck T, Beeckmans S. Smouts I, Ceulemans B, Lagae L, Buyse G, Barisic N, Misson JP, Wauters J, Del-Favero J, De Jonghe P and Claes LR Microdeletions involving the SCN1A gene may be common in SC/V/-mutation-negative SMEI patients. Hum Mutat (2006) 27 914-920.
33. Madia F, Striano P, Gennaro E, MalacarneM, Paravidino R Biancheri R, Budetta M, Cilio MR, Gaggero R, Pierluigi M Minetti C and Zara F: Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Neurology (2006) 67: 1230-1235.
34. Wang JW, Kurahashi H, Ishii A, Kojima T, Ohfu M, Inoue T. Ogawa A, Yasumoto S, Oguni H, Kure S, Fujii T, Ito M, Okuno T. Shirasaka Y, Natsume J, Hasegawa A, Konagaya A, Kaneko S and Hirose S: Microchromosomal deletions involving SCN1A and adjacent genes in severe myoclonic epilepsy in infancy. Epilepsia (2008)49: 1528-1534.
35. Marini C, Scheffer IE, Nabbout R, Mei D, Cox K, Dibbens LM McMahon JM, Lona X, Carpintero RS, Elia M, Cilio MR Specchio N, Giordano L, Striano P, Gennaro E, Cross JH, Kivity S, Neufeld MY, Afawi Z, Andermann E, Keene D, Dulac 0, Zara F, Berkovic SF, Guerrini R and Mulley JC: SCN1A duplications and deletions detected in Dravet syndrome: Implications for molecular diagnosis. Epilepsia (2009) 50: 1670-1678.
36. Nabbout R, Gennaro E, Dalla Bernardina B, Dulac 0, Madia F Bertini E, Capovilla G, Chiron C, Cristofori G, Elia M, Fontana E. Gaggero R, Granata T, Guerrini R, Loi M, La Selva L, Lispi ML, Matricardi A, Romeo A, Tzolas V, Valseriati D, Veggiotti P. Vigevano F, Vallee L, Dagna Bricarelli F, Bianchi A, and Zara F Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology (2003) 60: 1961-1967.
37. Wallace RH, Hodgson BL, Grinton BE, Gardiner RM, Robinson R Rodriguez-Casero V, Sadleir L, Morgan J, Harkin LA, Dibbens LM, Yamamoto T, Andermann E, Mulley JC, Berkovic SF and Scheffer IE: Sodium channel alphal-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology (2003) 61: 765-769.
38. Depienne C, Arzimanoglou A, Trouillard 0, Fedirko E, Baulac S. Saint-Martin C, Ruberg M, Dravet C, Nabbout R, Baulac M Gourfinkel-An I and LeGuern E: Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum Mutat (2006) 27: 389.
39. Gennaro E, Santorelli FM, Bertini E, Buti D, Gaggero R, Gobbi G Lini M, Granata T, Freri E, Parmeggiani A, Striano P, Veggiotti P. Cardinali S, Bricarelli FD, Minetti C and Zara F: Somatic and germline mosaicisms in Severe Myoclonic Epilepsy of Infancy. Biochem Biophys Res Commun (2006) 341: 489-493.
40. Marini C, Mei D, Helen Cross J and Guerrini R: Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia (2006)47: 1737-1740.
41. Morimoto M, Mazaki E, Nishimura A, Chiyonobu T, Sawai Y. Murakami A, Nakamura K, Inoue I, Ogiwara I, Sugimoto T and Yamakawa K: SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia (2006) 47: 1732-1736.
42. Depienne C, Trouillard 0, Gourfinkel-An I, Saint-Martin C Bouteiller D, Graber D, Barthez-Carpentier MA, Gautier A, Villeneuve N, Dravet C, Livet MO, Rivier-Ringenbach C, Adam C Dupont S, Baulac S, Heron D, Nabbout R and Leguern E Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J Med Genet (2010) 47: 404-410.
43. Selmer KK, Eriksson AS, Brandal K, Egeland T, Tallaksen C and Undlien DE: Parental SCN1A mutation mosaicism in familial Dravet syndrome. Clin Genet (2009) 76: 398-403
44. Meisler MH and Kearney JA: Sodium channel mutations in epi-lepsy and other neurological disorders. J Clin Invest (2005) 115 2010-2017.
45. Guerrini R, Cellini E, Mei D, Metitieri T, Petrelli C, Pucatti D Marini C and Zamponi N: Variable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene. Epilepsia (2010)51: 2474-2477.
46. Suls A, Velizarova R, Yordanova I, Deprez L, Van Dyck T. Wauters J, Guergueltcheva V, Claes LR, Kremensky I, Jordanova A and De Jonghe P: Four generations of epilepsy caused by an inherited microdeletion of the SCN1A gene. Neurology (2010) 75 72-76.
47. Singh NA, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, Thompson J, Dixon M, Gurnett C, Peiffer A, White HS, Filloux F and Leppert MF: A role of SCN9A in human epilep-sies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet (2009) 5: e1000649.
48. Ohmori I, Ouchida M, Miki T, Mimaki N, Kiyonaka S, Nishiki T. Tomizawa K, Mori Y and Matsui H: A CACNB4 mutation shows that altered Ca(v)2.1 function may be a genetic modifier of severe myoclonic epilepsy in infancy. Neurobiol Dis (2008) 32: 349-354.
49. Scheffer IE Turner SJ, Dibbens LM, Bayly MA, Friend K. Hodgson B, Burrows L, Shaw M, Wei C, Ullmann R, Ropers HH Szepetowski P, Haan E, Mazarib A, Afawi Z, Neufeld MY, Andrews PI, Wallace G, Kivity S, Lev D, Lerman-Sagie T, Derry CP, Korczyn AD, Gecz J, Mulley JC and Berkovic SF: Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain (2008) 131 (Pt 4): 918-927
50. Dibbens LM, Tarpey PS, Hynes K, Bayly MA, Scheffer IE, Smith R Bomar J, Sutton E, Vandeleur L, Shoubridge C, Edkins S, Turner SJ, Stevens C, O'MearaS, Tofts C, Barthorpe S, Buck G, Cole J Halliday K, Jones D, Lee R, Madison M, Mironenko T, Varian J. West S, Widaa S, Wray P, Teague J, Dicks E, Butler A, Menzies A, Jenkinson A, Shepherd R, Gusella JF, Afawi Z, Mazarib A, Neufeld MY, Kivity S, Lev D, Lerman-Sagie T, Korczyn AD Derry CP, Sutherland GR, Friend K, Shaw M, Corbett M, Kim HG, Geschwind DH, Thomas P, Haan E, Ryan S, McKee S. Berkovic SF, Futreal PA, Stratton MR, Mulley JC and Gecz J: X-inked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet (2008) 40: 776-781.
51. Depienne C, Bouteiller D, Keren B, Cheuret E, Poirier K. Trouillard O, Benyahia B, Quelin C, Carpentier W, Julia S. Afenjar A, Gautier A, Rivier F, Meyer S, Berquin P, HeliasM, Py I, Rivera S, Bahi-Buisson N, Gourfinkel-An I, Cazeneuve C Ruberg M, Brice A, Nabbout R and Leguern E: Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resem-bles Dravet syndrome but mainly affects females. PLoS Genet (2009)5: e1000381.
52. Yagi T and Takeichi M: Cadherin superfamily genes: function, genomic organization, and neurologic diversity. Genes Dev (2000) 14: 1169-1180.
53. Harkin LA, Bowser DN, Dibbens LM, Singh R, Phillips F. Wallace RH, Richards MC, Williams DA, Mulley JC, Berkovic SF, Scheffer IE and Petrou S: Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet (2002) 70: 530-536.
54. Patino GA, Claes LR, Lopez-Santiago LF, Slat EA, Dondeti RS Chen C, O'Malley HA, Gray CB, Miyazaki H, Nukina N, Oyama F. De Jonghe P and Isom LL: A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci 29 (2009) 10764-10778.
55. Shi X, Yasumoto S, Nakagawa E, Fukasawa T, Uchiya S and Hirose S: Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome. Brain Dev (2009) 31: 758-762
56. Lossin C: A catalog of SCN1A variants. Brain Dev (2009) 31 114-130.
57. Harkin LA, McMahon JM, Lona X, Dibbens L, Pelekanos JT, Zuberi SM, Sadleir LG, Andermann E, Gill D, Farrell K, Connolly M, Stanley T, Harbord M, Andermann F, Wang J, Batish SD Jones JG, Seltzer WK, Gardner A, The Infantile Epileptic Encephalopathy Referral Consortium, Sutherland G, Berkovic SF: Mulley JC and Scheffer IE: The spectrum of SC/V-related infan-tile epileptic encephalopathies. Brain (2007) 130: 843-852
58. Ebach K, Joos H, Doose H, Stephani U, Kurlemann G, Fiedler B Hahn A, Hauser E, Hundt K, Holthausen H, Muller U and Neubauer BA: SCN1A mutation analysis in myoclonic astatic epi-lepsy and severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics (2005) 36: 210-213.
59. Ohmori I, Ouchida M, Kobayashi K, Jitsumori Y, Inoue T. Shimizu K, Matsui H, Ohtsuka Y and Maegaki Y: Rasmussen encephalitis associated with SCN1A mutation. Epilepsia (2008) 49: 521-526